Senores Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,596	1,054	76.5	1	20.2
Short-Term Investments	-	2,801	52.1	-	11.95
Cash & Short-Term Investments	1,596	3,855	128.6	1	32.15
Cash Growth	-58.60%	2897.67%	12760.00%	-96.89%	-
Accounts Receivable	3,248	2,408	1,781	383.77	196.31
Other Receivables	-	0.6	-	-	-
Receivables	3,248	2,408	1,784	383.77	196.31
Inventory	892.9	566.3	373.7	31.24	29.83
Prepaid Expenses	-	72.1	30.3	12.02	0.14
Restricted Cash	-	-	2	-	-
Other Current Assets	2,387	322.7	190.5	85.34	12.09
Total Current Assets	8,124	7,224	2,509	513.37	270.52
Property, Plant & Equipment	3,627	2,524	1,791	152.64	61.16
Long-Term Investments	42.9	13.3	194.9	168.54	155.48
Goodwill	465.5	382.1	382.1	-	-
Other Intangible Assets	3,388	1,826	1,152	464.43	88.42
Long-Term Deferred Tax Assets	-	186.7	149.6	-	4.51
Other Long-Term Assets	390.4	112.4	40	10.57	1.07
Total Assets	16,038	12,269	6,219	1,311	591.52
Accounts Payable	2,347	672.2	1,130	135.82	71.36
Accrued Expenses	-	107.1	80.5	10.68	2.12
Short-Term Debt	1,322	312.1	323.9	81.57	19.91
Current Portion of Long-Term Debt	-	1,111	823.4	228.74	-
Current Portion of Leases	17.6	17.9	14.8	2.48	1.41
Current Income Taxes Payable	202.3	134.9	71.1	15.85	1.28
Other Current Liabilities	350.9	51.9	31.2	43.69	2.77
Total Current Liabilities	4,240	2,407	2,475	518.83	98.85
Long-Term Debt	1,949	1,625	1,337	297.32	122.16
Long-Term Leases	131.8	82	77.8	15.83	4.07
Pension & Post-Retirement Benefits	-	13.3	7.7	1.48	0.54
Long-Term Deferred Tax Liabilities	5.9	-	-	20.96	-
Other Long-Term Liabilities	66.1	19.2	4.7	1.12	-
Total Liabilities	6,393	4,146	3,902	855.54	225.62
Common Stock	460.5	460.5	305.1	98.15	87.42
Retained Earnings	-	7,450	1,758	352.91	252.49
Comprehensive Income & Other	8,876	-48.3	-20.5	3.93	25.99
Total Common Equity	9,336	7,862	2,043	454.99	365.9
Minority Interest	309.4	260.6	274.4	-	-
Shareholders' Equity	9,645	8,123	2,317	454.99	365.9
Total Liabilities & Equity	16,038	12,269	6,219	1,311	591.52
Total Debt	3,420	3,148	2,576	625.94	147.55
Net Cash (Debt)	-1,824	707.5	-2,448	-624.94	-115.4
Net Cash Per Share	-41.37	19.45	-94.99	-49.27	-21.05
Filing Date Shares Outstanding	39.71	46.05	33.27	9.82	9.82
Total Common Shares Outstanding	39.71	46.05	30.5	9.82	9.82
Working Capital	3,884	4,817	34.1	-5.46	171.67
Book Value Per Share	235.10	170.71	66.96	46.36	37.28
Tangible Book Value	5,483	5,654	508.6	-9.44	277.48
Tangible Book Value Per Share	138.06	122.77	16.67	-0.96	28.27
Land	-	499.4	499.3	53.01	53.02
Buildings	-	791.3	497.8	-	-
Machinery	-	885.6	589.4	2.93	0.45
Construction In Progress	-	441.7	177.7	80.55	3.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.